Connection
Sarah Johnson to Molecular Targeted Therapy
This is a "connection" page, showing publications Sarah Johnson has written about Molecular Targeted Therapy.
|
|
Connection Strength |
|
|
|
|
|
0.092 |
|
|
|
-
Johnson SK, Heuck CJ, Albino AP, Qu P, Zhang Q, Barlogie B, Shaughnessy JD. The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma. Int J Hematol. 2011 Oct; 94(4):321-333.
Score: 0.092